Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shion A Lim

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2022
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null DiseaseNing Zhao, Shalini Chopra, Kai Trepka, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Nature Cell Biology|January 14, 2022
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Nature|February 5, 2025
IL-27 elicits a cytotoxic CD8<sup>+</sup> T cell program to enforce tumour controlBéatrice Bréart, Katherine Williams, Stellanie Krimm, et al.
JCI Insight|May 22, 2025
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19Anita E Qualls, Tasha Tsao, Irene Lui, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 23, 2022
CUB Domain-Containing Protein 1 (CDCP1) Is a Target for Radioligand Therapy in Castration-Resistant Prostate Cancer, including PSMA Null DiseaseNing Zhao, Shalini Chopra, Kai Trepka, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2021
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Nature Cell Biology|January 14, 2022
BRD2 inhibition blocks SARS-CoV-2 infection by reducing transcription of the host cell receptor ACE2Avi J Samelson, Quang Dinh Tran, Rémy Robinot, et al.
Nature|February 5, 2025
IL-27 elicits a cytotoxic CD8<sup>+</sup> T cell program to enforce tumour controlBéatrice Bréart, Katherine Williams, Stellanie Krimm, et al.
JCI Insight|May 22, 2025
High-affinity CD16A polymorphism associated with reduced risk ofsevere COVID-19Anita E Qualls, Tasha Tsao, Irene Lui, et al.
Pageof 3